Benyam Yoseph, MD
General Practice · Orlando, FLNPI 1114312261
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Johnson & Johnson at 32.0% of the total. Reporting peaked in 2023 at $99 and has fallen 80.8% since, to $19 in 2025. That places this record below the midpoint for general practice clinicians in FL, where the typical reported total is $253.
Across 11 payments — averaging $26.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$95
- Lilly USA, LLC$83
- Alcon$69
- Next Science LLC$49
What the payments were for
- Food & beverage$296100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $95 |
| Lilly USA, LLC | 2 | $83 |
| Alcon | 4 | $69 |
| Next Science LLC | 4 | $49 |
How this compares
$296 in reported general payments places this provider in the 50th percentile of 6,901 general practice providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 54 | $44,978 |
| Ketoconazole | 21 | $1,103 |
| Doxycycline Hyclate | 29 | $1,020 |
| Mupirocin | 16 | $287 |
| Fluconazole | 11 | $244 |
| SsdSilver Sulfadiazine | 12 | $241 |
| Losartan Potassium | 12 | $86 |
| Furosemide | 11 | $51 |
Paid to pharmacies, not to this prescriber.
Other general practice in Orlando
- Ross EnfingerOrlando$53K
- Jose MarcanoOrlando$52K
- Thomas LacyOrlando$15K
- Amy HertzOrlando$13K
- Robert VogelPalm Beach Gardens$1M
- Bruce OuelletteWest Palm Beach$724K
- Caley CasteleinMiami Beach$586K
- Sarah JockinTampa$308K
- Mario RomeroSarasota$275K
- Robert RitterJupiter$233K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.